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Key messages
What is already known about this subject?
 ► Anticitrullinated protein/peptide antibodies 
(ACPAs) exist prior to the onset of rheumatoid 
arthritis (RA), however, it is unclear how 
autoimmunity in some but not all cases 
translate into manifest joint inflammation.
What does this study add?
 ► Cellular stress and pro-inflammatory mediators 
(interleukin-8) can sensitise synovial fibroblasts 
to ACPAs by enhancing protein arginine 
deiminase enzyme expression and cellular 
citrullination.
 ► ACPAs promote synovial fibroblast migration 
through a phosphoinositide 3-kinase-mediated 
mechanism.
 ► Different monoclonal ACPAs have distinct 
cellular effects with three clones increasing 
migration of challenged fibroblasts, with 
no effect on osteoclasts and another clone 
increasing osteoclast differentiation with no 
effect on fibroblasts.
How might this impact on clinical practice or 
future developments?
 ► Our results suggest that unique ACPAs may be 
responsible for specific pathological features in 
ACPA+RA.
 ► Inducible protein citrullination could be a key 
event in the transition of a systemic humoral 
autoimmunity towards the inflammation of the 
joints.
AbsTRACT
Objectives rheumatoid arthritis (ra)-specific anti-
citrullinated protein/peptide antibodies (acPas) might 
contribute to bone loss and arthralgia before the onset 
of joint inflammation. We aimed to dissect additional 
mechanisms by which acPas might contribute to 
development of joint pathology.
Methods Fibroblast-like synoviocytes (Fls) were 
isolated from the synovial membrane of patients with ra. 
The Fls cultures were stimulated with polyclonal acPas 
(anti-ccP-2 antibodies) purified from the peripheral 
blood of patients with ra or with monoclonal acPas 
derived from single synovial fluid B cells. We analysed 
how acPas modulate Fls by measuring cell adhesion 
and mobility as well as cytokine production. expression 
of protein arginine deiminase (PaD) enzymes and protein 
citrullination were analysed by immunofluorescence, and 
signal transduction was studied using immunoblotting.
Results challenge of Fls by starvation-induced stress or 
by exposure to the chemokine interleukin-8 was essential 
to sensitise the cells to acPas. These challenges led to an 
increased PaD expression and protein citrullination and 
an acPa-mediated induction of Fls migration through 
a mechanism involving phosphoinositide 3-kinase 
activation. inhibition of the PaD enzymes or competition 
with soluble citrullinated proteins or peptides completely 
abolished the acPa-induced Fls migration. Different 
monoclonal acPas triggered distinct cellular effects in 
either fibroblasts or osteoclasts, suggesting unique roles 
for individual acPa clones in disease pathogenesis.
Conclusion We propose that transient synovial insults 
in the presence of a certain pre-existing acPa repertoire 
might result in an acPa-mediated increase of Fls 
migration.
InTROduCTIOn
Anti-citrullinated protein antibodies (ACPAs) are 
present in a majority of patients with rheumatoid 
arthritis (RA) and are specific for this disease.1 They 
consist of a group of antibodies with different spec-
ificities towards citrullinated antigens that might 
cross-react with other protein modifications but not 
with the native proteins2–4 and have been suggested 
to contribute to joint pain and bone loss already 
before onset of joint inflammation in RA.5–8 In line 
with this, we and others have shown that polyclonal 
ACPAs bind to the surface of developing osteoclasts 
(OC) and suggested that reactivity to citrullinated 
targets increase OC differentiation and bone loss.9 10 
Furthermore, experiments in mice have shown that 
polyclonal ACPAs (defined as anti-CCP-2 IgG 
antibodies) induces pain-related behaviours even 
though no joint inflammation develops,11 similar to 
the predisease stage of pain described in ACPA-posi-
tive individuals. We originally proposed that this, as 
well as ACPA-induced bone loss in mice, occurred 
through an interleukin (IL)-8-dependent and citrul-
line-specific mechanisms.10 11 However, recent 
papers and corrections12 13 this year have led to a 
reconsideration and extension of the concept. As 
such also other RA-derived monoclonal antibodies 
Zentralbibliothek Zuerich. Protected by copyright.
 o
n
 N
ovem
ber 5, 2019 at UZH Hauptbibliothek /
http://ard.bmj.com/
Ann R
heum
 D
is: first published as 10.1136/annrheum
dis-2018-214967 on 3 Septem
ber 2019. Downloaded from
 
2 Sun M, et al. Ann Rheum Dis 2019;0:1–11. doi:10.1136/annrheumdis-2018-214967
Rheumatoid arthritis
than those with citrulline reactivity and immune complexes are 
able to cause functional effects similar to those of polyclonal 
ACPAs, through different mechanisms that are potentially 
distinct between autoantibody subsets and might include both 
antigen-driven and Fcγ receptor activation-driven pathways.14–16 
Taken together, these data suggest a new concept where different 
RA-associated antibodies with different reactivities contribute to 
bone loss and pain, potentially through different mechanisms, 
a complex scenario that requires additional investigations. The 
need for these investigations and the ways of performing them 
has been highlighted in a recent editorial.17
Previous studies have shown that in the presence of pre-ex-
isting joint inflammation in mice, transfer of a monoclonal 
ACPA may enhance synovial tissue injury,18 suggesting that 
additional local stimuli might be essential for sensitisation of 
the synovial compartment to effects of antibodies. In the syno-
vial tissue, fibroblast-like synoviocytes (FLS) contribute to an 
inflammatory stroma that promote and amplify tissue-specific 
immune activation through the release of various cytokines and 
have the capacity to grow into the cartilage surface and create 
an erosive interface by producing tissue remodelling proteases, 
such as matrix metalloproteinases and cathepsins.19 RA-derived 
FLS have also an increased migration capacity, a feature that 
might contribute to disease propagation within and in between 
the joints.20 21
In the present report, we investigated ACPA effects on FLS. We 
demonstrate that stimuli such as cellular stress and/or exposure 
to pro-inflammatory mediators are needed for the sensitisation 
of FLS to ACPAs. Furthermore, some but not all ACPAs are able 
to affect FLS. Our findings thereby suggest that transient syno-
vial insults in the presence of certain pre-existing ACPA clones 
might act in concert to promote ACPA-mediated FLS migration.
MATeRIAls And MeTHOds
Additional detailed information is provided in online supple-
mentary file.
Patient material
Polyclonal ACPA IgGs (anti-CCP2 antibodies) and non-ACPA 
control IgGs were purified from a pooled serum of patients 
with RA22 and from non-pooled sera of four ACPA-positive 
patients with RA (for details see online supplementary file). 
Using a similar method, polyclonal antiproteinase 3 (PR3) IgGs 
and non-anti-PR3 control IgGs were purified from the sera of 
a patient with PR3-associated vasculitis. Monoclonal antibodies 
were isolated from patients with RA as previously described2 4 15 
and recombinantly expressed as IgG1. All IgG underwent exten-
sive quality control testing including specificity evaluation, size 
exclusion chromatography aggregation test and limulus amebo-
cyte lysate (LAL) endotoxin test.23 F(ab’)2 antibody fragments 
were generated and RF IgM antibody was purchased from 
Athens Research & Technology (Georgia, USA). RA-derived 
and osteoarthritis (OA)-derived synovial fibroblasts as well as 
human dermal fibroblasts were used in cell culture experiments. 
Synovial biopsies were obtained from four healthy volunteers 
and four patients with RA. Patients were enrolled at Karolinska 
University Hospital. Informed consent was obtained according 
to the protocol approved by the Ethical Review Committee 
North of Karolinska University Hospital.
Migration and adhesion assays
Fibroblast migration was assessed by IncuCyte Zoom live 
cell imaging system or by scratch assay. Adhesion assays were 
performed using 16-well E-plates and the xCELLigence System 
Real-Time Cell Analyzer (ACEA Biosciences, USA). When indi-
cated, the cells were washed with phosphate buffered saline 
and starved for 2 hours in medium without fetal bovine serum. 
Citrullinated or native human purified fibrinogen, recombinant 
vimentin, α-enolase and histone H4 were added as pretreatment 
to ACPA and control IgGs at 4°C overnight. Phosphoinositide 
3-kinase (PI3K) was inhibited by wortmanin and phosphatase and 
tensin homolog (PTEN) by SF-1670 (Sigma-Aldrich, Stockholm, 
Sweden). PAD activity was inhibited by Cl-amidine (Cayman 
Chemical, Ann Arbor, Michigan, USA) or GSK199 (kind gift 
from Aaron Winkler, Pfizer) for 72 hours prior to scratching. 
Histone acetyltransferase or deacetylase enzymes were inhibited 
by anacardic acid or trichostatin A (Sigma-Aldrich, Stockholm, 
Sweden), respectively. Fibroblasts were cultured in the presence 
or absence of IL-8 (R&D Systems, Abingdon, UK) or tumour 
necrosis factor (TNF)-α (Peprotech, London, UK). Cytokine 
levels were analysed using the Cytometric Bead Array (BD Biosci-
ences, San Diego, California, USA) and matrix metalloprotein-
ases were measured by ELISA (R&D Systems, Abingdon, UK).
Immunohistochemistry and confocal microscopy
FLS were stained with indicated primary antibodies followed 
by horseradish peroxidase (HRP)-conjugated antibodies and 
developed by Vectastain Elite ABC and DAB (Vector Laborato-
ries, Peterborough, UK) and then counterstained with Mayer’s 
haematoxylin. For confocal microscopy, cells and tissues incu-
bated with primary and secondary antibodies and then counter-
stained with 4,6-diamidino-2-phenylindole.
Mass spectrometry
Starved and non-starved FLS whole cell lysate were analysed by 
mass spectrometry for detection of citrullination.
Western blot analysis
Cells lysates were loaded an SDS-PAGE gel (Bio-Rad, Solna, 
Sweden), transferred to nitrocellulose membranes and incubated 
with primary antibodies and peroxidase-conjugated secondary 
antibodies.
Flow cytometry
Cells were collected using non-enzymatic detachment reagent 
(Sigma-Aldrich, Stockholm, Sweden), stained by fluoro-
chrome-labelled antibodies and analysed by FACSVerse flow 
cytometer (BD Biosciences, San Jose, California, USA).
statistical analysis
The data were analysed using either Kurskal-Wallis test followed 
by Dunn’s multiple comparation test or two-way analysis of vari-
ance, followed by Tukey’s post hoc test by using GraphPad Prism 
6 software (GraphPad Software, San Diego, California, USA). P 
values <0.05 were considered to be statistically significant.
ResulTs
Polyclonal ACPAs enhance migration and adhesiveness in 
starved Fls
To test if FLS are or might be rendered sensitive to ACPAs, we 
compared the effects of polyclonal ACPA and non-ACPA control 
IgGs on FLS migration in both basal conditions and after chal-
lenging by a 2-hour serum starvation. Neither polyclonal ACPA 
IgGs nor non-ACPA control IgGs had any effect on the migration 
of non-starved FLS (figure 1A). In contrast, polyclonal ACPA 
IgGs, but not non-ACPA control IgGs, increased the migration 
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Figure 1 Increased mobility and adherence of synovial fibroblasts in presence of polyclonal ACPAs. Cell mobility was analysed during a period of 
6 hours in the presence of 1 µg/mL polyclonal ACPA IgGs (ACPA) or non-ACPA control IgGs (IgG) or without antibody treatment (-) in both non-starved 
(A) and starved (B) fibroblast cultures. The graphs represent mean±SD values obtained from 10 independent experiments, using cells of 10 different 
patients and 6 replicates for each treatment. Dot line indicate migration index of non-treated FLS. Image-based evaluation of cell migration in starved 
fibroblast cultures were performed using phase contrast microscopy with 10x magnification (C). Real-time cell migration was measured in the 
presence of 1 µg/mL ACPA or control IgG or without any treatment in non-starved (D) and starved (E) fibroblast cultures using IncuCyte. The graphs 
represent mean±SD values obtained by using cells from 10 individuals patients and 6 replicates in 10 independent experiments. A titration experiment 
was performed on starved synovial fibroblasts with presence of ACPA (F) and anti-PR3 (G) with indicated concentrations. (H) Cell mobility were tested 
on starved FLS with presence of 1 µg/mL anti-MDA antibodies (1276:01F04, 1362:03H05 and 146+:01G07). The graphs represent mean±SD values 
obtained from five replicates in three independent experiments for anti-PR3 titration and anti-MDA antibodies. Starved FLS mobility was analysed by 
combining 0.5 µg/mL ACPA with 0.5 µg/mL IgM RF (I) and 1 µg/mL ACPA with 1 µg/mL IgM RF (J). The graphs represent mean±SD values obtained from 
three different patients with six replicates in three independent experiments. Effect of ACPA IgGs fractions prepared from individual blood samples 
were tested on starved synovial fibroblasts using the indicated concentrations (K). The graphs represent results obtained from cells of three different 
patients, using six replicates in three independent experiment. Real-time cell adherence was monitored in the presence of 1 µg/mL ACPA, control IgG 
or without antibody treatment in starved fibroblast cultures for up to 6 hours. The chart shows representative results in one experiment (L), whereas 
the graph indicates mean±SD values of slope during real-time cell adherence assay, calculated from five different patients with three replicates 
in five independent experiments (M). *P<0.05. ACPA, anticitrullinated protein/peptide antibody; FLS, fibroblast-like synoviocytes; PR3, polyclonal 
antiproteinase 3; ns, not significant; RF, rheumatoid factor.
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index of starved FLS with a mean±SD fold of 2.6±0.3 for ACPA 
IgGs as compared with 0.95±0.2 for non-ACPA control IgGs, 
p<0.05 (figure 1B,C). ACPA IgGs had no effect on cell viability 
and proliferation (online supplementary figure 1). Similar 
results were seen for OA-derived synovial fibroblasts and human 
dermal fibroblasts (online supplementary figure 2). The increase 
in cell mobility was observed as early as 6 hours and was stable 
up to 20 hours after ACPA exposure (figure 1D,E). Dose titra-
tion showed an optimal effect at 1 µg/mL (figure 1F). In contrast, 
polyclonal anti-PR3 autoantibodies prepared in a similar way as 
ACPA showed no effect on starved FLS migration at doses as high 
as 5 µg/mL (figure 1G). Furthermore, monoclonal anti-malondi-
aldehyde(MDA) antibodies obtained through the same method-
ology as the monoclonal ACPAs had no effect on FLS migration 
(figure 1H). Interestingly, addition of IgM RF to the cultures 
significantly potentiated the effect of suboptimal (figure 1I) but 
not higher concentrations of the polyclonal ACPAs (figure 1J), 
while showing no effect when used alone (at doses as high as 
5 µg/mL, online supplementary figure 3). Some but not all ACPA 
IgG fractions prepared from individual blood samples were able 
to recapitulate the effect observed with the ACPA IgGs prepared 
from pooled blood samples (figure 1K).
Besides migration, ACPA IgGs were able to increase adhesive-
ness of starved FLS (figure 1L), with an average slope increase 
of 0.44±0.04 for polyclonal ACPA IgGs as compared with 
0.24±0.05 for non-ACPA control IgGs, p<0.05 (figure 1M). 
Notably, ACPAs did not influence either matrix invasion (data 
not shown), matrix metalloproteinases production or cytokine 
and chemokine levels (online supplementary figure 4).
Inducible protein citrullination is essential for the ACPAs 
effect on Fls migration
To investigate the mechanisms that render FLS sensitive to 
ACPAs, we analysed the expression of PAD-2 and PAD-4, two 
PAD enzymes known to be present in RA synovium,24 and 
cellular citrullination following serum starvation. Non-starved 
FLS express low levels of intracellular PAD-2 and PAD-4 and 
do not bind polyclonal ACPA (figure 2A, upper panel). Cellular 
starvation significantly increased PAD-2 and PAD-4 enzymes 
expression in a majority of the cultured cells, as well as the 
amounts of citrullinated proteins labelled by polyclonal ACPA 
IgGs (figure 2A, lower panel and online supplementary figure 5). 
This was confirmed by mass spectrometry showing an increase 
in the number and the amount of citrullinated targets (estimated 
by label-free quantitative analysis) in starved as compared with 
non-starved FLS (online supplementary figure 6). Pre-incubation 
of the polyclonal ACPA with citrullinated (cit) but not native 
fibrinogen abolished FLS staining by ACPAs (figure 2B), as well 
as the ACPA-induced migration of starved FLS, an effect that 
titrated out at a protein:antibody ratio of 2:1 (figure 2C). Addi-
tional experiments demonstrated a similar effect for cit-vimentin 
and cit-enolase but not for cit-histone 4 (figure 2D). In line with 
this, inhibition of cellular citrullination by pretreatment with 
PAD inhibitors prevented both ACPA-staining (figure 2E) and 
the ACPA-induced migration of starved FLS (figure 2F), without 
affecting proliferation and cell viability (online supplementary 
figure 1). Furthermore, F(ab’)2 ACPA fragments had a similar 
capacity to induce migration of starved FLS (figure 2G), in line 
with lack of expression of Fcγ receptors by FLS (online supple-
mentary figure 7).
PI3K activation is required forACPA-induced FLS migration
To gain insight into the intracellular signals activated by 
ACPAs, we investigated two major regulators of FLS migration: 
PI3K and mitogen-activated protein kinases (MAPK). Poly-
clonal ACPAs induced a transient but robust peak in Akt phos-
phorylation at the Thr308 residue linked to PI3K activation 
(figure 3A left and middle panels and figure 3B), whereas Akt 
phosphorylation at the Ser473 residue, linked to mammalian 
target of rapamycin activation, seemed to occur irrespectively 
of the presence of ACPAs (figure 3A left and middle panels). 
MAPK phosphorylation showed no differences between poly-
clonal ACPA and control IgGs. In contrast to the rather selective 
modulation of Akt by ACPAs, control treatment with TNF-α-in-
duced prolonged and broad phosphorylation events (figure 3A, 
right panels). PI3K inhibition almost completely abolished the 
ACPA-induced migration of starved FLS (figure 3C). Further-
more, increased stimulation of PI3K by blocking PTEN led to 
higher cellular mobility with no further increment by ACPAs 
(figure 3D).
Inflammatory stimuli can substitute starvation and sensitise 
Fls to ACPAs
To identify additional factors that may render FLS sensitive to 
ACPAs, we investigated the potential contribution of pro-in-
flammatory stimuli, such as IL-8 and TNF-α. FLS express IL-8 
receptors CXCR1 and CXCR2 (figure 4A) and produce low 
levels of IL-8, unaffected by ACPAs (online supplementary 
figure 4). Exogenously added IL-8 had no effect on the migra-
tion of non-starved (figure 4B) or starved (figure 4C) FLS, but 
significantly potentiated the effect of polyclonal ACPAs in both 
cultures. The synergistic effects were further demonstrated by 
combination of different concentrations of ACPAs with a fixed 
dose of IL-8 (figure 4D) or suboptimal concentration of ACPAs 
with increasing concentration of IL-8 (figure 4E). TNF-α trig-
gered a significant increase in FLS migration both in the pres-
ence or absence of ACPAs, suggesting different mechanisms 
triggered by these two cytokines (figure 4F). Similar to cell star-
vation, exogenous IL-8 significantly increased PAD-2 and PAD-4 
expression (figure 4G), as well as the amount of citrullinated 
proteins (figure 4H) in non-starved FLS (see also online supple-
mentary figure 5).
different ACPA clones induce Fls migration and osteoclast 
activation
Since polyclonal ACPA IgGs contain a wide spectrum of anti-
bodies, we investigated whether monoclonal ACPAs differ in their 
capacity to affect distinct cellular functions such as FLS mobility 
and OC differentiation. Among eight monoclonal ACPAs, each 
with different patterns of antigen recognition, three of them 
(1325:01B09, 14CFCT2D09 and 14CFCT2H12), enhanced 
FLS migration significantly (figure 5A, for titration curves see 
online supplementary figure 8), while not having any effect on 
OC differentiation (figure 5B). Interestingly, clone 1325:01B09 
but not 14CFCT2D09 and 14CFCT2H12 are cross-reac-
tive with homo-citrullinated targets.4 25 In contrast, clone 
1325:04C03, having no effect on FLS migration (figure 5A), 
significantly increased osteoclastogenesis (figure 5B) already at a 
concentration of 1 µg/mL. Selective cellular activation correlated 
with binding of clone 1325:01B09 to starved FLS and clone 
1325:04C03 to OC (figure 5C). Binding of 1325:01B09 to FLS 
(figure 5D) was prevented by pre-incubation with cit-fibrin-
ogen or cit-histone H4 but not by cit-vimentin or cit-enolase 
(figure 5E,F). As 1325:01B09 also cross-react with acetylated 
modified proteins,25 we performed further experiments to show 
that altered citrullination but not acetylation could modulate 
1325:01B09 effect on FLS (figure 5G). Furthermore, F(ab’)2 
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Figure 2 Starvation-induced protein citrullination is essential for synovial fibroblast migration induced by ACPAs. Confocal microscopy images 
visualise PAD-2 (green) and PAD-4 (red) expressions as well as polyclonal ACPA IgGs (ACPA) and non-ACPA control IgG (IgG) binding patterns in FLS 
cultures following serum withdrawal (starved) or in non-starved FLS, in the presence of 10% fetal bovine serum (A). An original magnification of 400x 
was used for all images obtained with confocal microscopy and nuclei are shown in blue. Starved FLS cultures were also stained with ACPAs (red 
colour) pre-incubated overnight with citrullinated (cit) or native fibrinogen with ratio of protein:antibody (10:1) (cit-Fib or Arg-Fib, respectively) or in 
the absence of fibrinogen (B). To block ACPA-induced migration, FLS migration was compared in the presence of 1 µg/mL polyclonal ACPAs and control 
IgG or with both antibodies pre-incubated with citrullinated or native fibrinogen in the indicated ratio overnight. Migration index was calculated from 
three independent experiments, using cells of three individual patients and six replicates for each treatment, mean±SD values are shown (C). Similar 
blocking experiments were performed with citrullinated vimentin (Vim), enolase (Eno) and histone 4 (His) using 10:1 decoy protein:antibody ratio . 
The graphs represent results obtained from three independent experiments, using cells of three individual patients and six replicates (D). To inhibit 
PAD enzymes, we exposed FLS cultures to 200 nM Cl-amidine for 72 hours. Confocal microscopy images show the inhibition of ACPA binding (red 
colour) to Cl-amidine pretreated FLS (E). Moreover, after pre-incubation of the cells with different PAD inhibitors, Cl-amidine and GSK199, we could 
not detect an increased FLS mobility in the presence of ACPAs (F). Migration index was calculated from three independent experiments, using cells of 
three individual patients and six sample-replicates, mean±SD values are shown. Furthermore, FLS migration were analysed in the presence of 0.7 µg/
mL polyclonal ACPA F(ab’)2 and non-ACPA IgG F(ab’)2. The graph indicates results obtained from three independent experiments, using cells of three 
individual patients and six replicates (G). *P<0.05. ACPA, anticitrullinated protein/peptide antibody; DMSO, dimethyl sulfoxide; FLS, fibroblast-like 
synoviocytes; PAD, protein arginine deiminase; ns, not significant.
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Figure 3 Role of PI3K in the ACPA-induce synovial fibroblast migration. Starved FLS were exposed to 1 µg/mL polyclonal ACPA IgG (ACPA) or 
non-ACPA control IgG (IgG) or to TNF 10 ng/mL. Immunoblot analysis of Akt (Thr308 or Ser473 residues), ERK1/2, JNK and p38 phosphorylation are 
shown, whereas GAPDH protein was detected as control. The presented data are representative for at least three independent experiments for all 
tested proteins (A). Change of Akt phosphorylation at the Thr308 residue is shown in response to 1 µg/mL ACPA or IgG treatments (B). The data were 
calculated following densitometry analysis in five independent experiments, levels were normalised to baseline intensities, mean±SD values are 
shown. FLS were pretreated with 200 nM of the PI3K inhibitor wortmannin (C) or 2 µg/mL of the PTEN inhibitor SF-1670 (D) for 2 hours prior to the 
analysis of cell migration in the presence of 1 µg/mL ACPA or control IgG. DMSO (0.01%) was used as solvent control. Graphs represent fold-change in 
cell mobility, mean±SD values were calculated from three independent experiments, *P<0.05. ACPA, anticitrullinated protein/peptide antibody; DMSO, 
dimethyl sulfoxide; FLS, fibroblast-like synoviocytes; PAD, protein arginine deiminase; PI3K, phosphoinositide 3-kinase; PTEN, phosphatase and tensin 
homolog; ns, not significant; TNF, tumour necrosis factor.
fragments of 1325:01B09 enhanced migration of (figure 5H) and 
bound to non-permeabilised (figure 5I) challenged FLS which 
was prevented by exogenously added cit-fibrinogen (figure 5J). 
Both whole and F(ab’)2 fragments of 1325:01B09 were able to 
promote migration of challenged FLS through a similar mecha-
nism as for the polyclonal ACPA IgGs, as shown by activation of 
the PI3K pathway (figure 5K).
We further investigated cellular binding patterns in synovial 
biopsies obtained from both healthy volunteers and patients with 
RA. None of the ACPA clones labelled the uninflamed synovial 
tissues (figure 6A). In contrast, we detected 1325:01B09 binding 
to multiple cells from the dense layer of CD55 and podo-
planin-(PDPN)-positive fibroblasts in the synovial membrane of 
two out of the four tested inflamed RA synovial tissues, whereas 
virtually no binding of the clone 1325:04C03 was observed in 
the CD55 and/or PDPN-positive areas (figure 6B). No correla-
tion was seen between the staining pattern and disease charac-
teristics. The co-localisation of 1325:01B09 binding sites with 
CD55-positive (figure 6C) and PDPN-positive FLS (figure 6D), 
as well as co-localisation of the F(ab’)2 1325:01B09 fragments 
with PDPN-positive FLS (figure 6E) was further confirmed 
in two additional inflamed RA synovial tissue using confocal 
microscopy.
dIsCussIOn
In this report, we describe that steady-state FLS are unrespon-
sive to ACPAs but can be rendered sensitive to these autoan-
tibodies in the presence of additional stimuli. A key event in 
priming synovial fibroblasts to ACPA is an inducible PAD-2 
and PAD-4 expression that is accompanied by increased protein 
citrullination. Importantly, individual monoclonal ACPAs exhib-
ited different capacities to induce migration of challenged FLS 
and activate OC. We provide novel insights into how different 
ACPA clones in concert might contribute to distinct pathogenic 
events in the RA development. Furthermore, PAD inhibition 
may be beneficial in targeting FLS during the development of 
ACPA-positive arthritis.
We demonstrated that polyclonal ACPA IgGs are able to induce 
migration and adhesiveness of challenged fibroblasts, inde-
pendent of their tissue origin. This poses challenges in under-
standing the specific targeting of the synovial tissue in RA. While 
tissue-specific antibody-induced vascular changes26 and site-spe-
cific differences in the responses to pro-inflammatory cytokine 
priming in skin versus synovial fibroblasts27 might play a role, 
further research is needed to clarify this issue. The lack of effects 
of polyclonal ACPAs on steady-state fibroblasts is in accordance 
with the clinical observation that ACPAs alone are not sufficient 
for development of arthritis in seropositive individuals28 and 
the fact that ACPA infusion in mice does not induce arthritis.11 
In contrast, challenging by transient cellular stress or exposure 
to pro-inflammatory signals render the FLS sensitive to ACPA 
effects. Furthermore, while not having a direct effect on FLS, RF 
is able to potentiate the ACPAs effects on the FcγR-negative FLS, 
potentially by forming complexes with the cell bound ACPAs and 
consequently recruiting more of the activated surface molecules, 
which are engaged in ACPA interactions, as well as their associ-
ated signalling components.29–33 Our findings provide support 
to the concept of a stepwise involvement of several molecular 
mechanisms in ACPA-mediated synovial pathology. Transient 
synovial events such as trauma34–38 or viral infections,39 40 which 
Zentralbibliothek Zuerich. Protected by copyright.
 o
n
 N
ovem
ber 5, 2019 at UZH Hauptbibliothek /
http://ard.bmj.com/
Ann R
heum
 D
is: first published as 10.1136/annrheum
dis-2018-214967 on 3 Septem
ber 2019. Downloaded from
 
7Sun M, et al. Ann Rheum Dis 2019;0:1–11. doi:10.1136/annrheumdis-2018-214967
Rheumatoid arthritis
Figure 4 Collaboration of ACPA-mediated signals with the inflammatory cytokines IL-8 and TNF in inducing FLS migration. CXCR1 and CXCR2 
expressions in FLS cultures were analysed with immunohistochemistry by light microscopy with the original magnification of 250x (left panel) and 
flow cytometry (right panel) (A). Migration of non-starved (B) and starved FLS (C) were assessed after exposing the cells to suboptimal (0.5 µg/mL) 
dose of ACPA or IgG in the presence or absence of 10 ng/mL recombinant human IL-8. Mean±SD values were calculated from three independent 
experiments, using cells of five individual patients and three replicates, *p<0.05. Starved FLS mobility was analysed by combining high dose (10 ng/
mL) of IL-8 with increasing ACPA concentrations (D) or suboptimal concentration of ACPA with increasing concentrations of IL-8 (E). On similar 
grounds, increasing concentrations of TNF were combined with ACPA applied at a suboptimal dose (F). Mean±SD values were calculated based on 
at three independent experiments, using cells of three different patients and six sample replicates, *p<0.05 (G). Confocal microscopy images show 
increased PAD-4 (red colour) and PAD-2 (green colour) expression of non-starved FLS cultures stimulated by IL-8 (10 ng/mL). Nuclei are represented 
in blue colour. The effect of IL-8 (10 ng/mL) was also tested on ACPA binding to FLS cultures using confocal microscopy (H). Red colour represents 
antibody binding, nuclei are shown in blue, The original magnification was 400x. The right panels represent a zoomed area from the original images. 
ACPA, anticitrullinated protein/peptide antibody; DAPI, 4,6-diamidino-2-phenylindole; FLS, fibroblast-like synoviocytes; IL, interleukin; PAD, protein 
arginine deiminase; ns, not significant; SF, synovial fluid; TNF, tumour necrosis factor.
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Figure 5 The monoclonal ACPAs 1325:01B09 and 1325:04C03 display selective binding and stimulatory capacities on FLS and osteoclasts. The 
effects of eight individual ACPA clones were tested in concentration of 1 µg/mL on fibroblast migration (A) and osteoclast differentiation (B) assays. 
The graphs represent migration index expressed as fold-difference normalised to untreated controls using data from three independent experiments, 
using cells of three different patients, all performed six replicate samples, *p<0.05. Osteoclast counts expressed in fold-difference normalised to 
untreated controls using data from two to five independent experiments, performed at least three replicates, *p<0.05. IHC stainings show binding 
capacity of individual ACPA clones, 1325:01B09 and 1325:04C03 to FLS and osteoclasts (C). Confocal microscopy images illustrate the binding of 
the ACPA clones (1325:01B09, 1325:04C03) and control (1362:01E02) monoclonal antibodies (red colour) to starved FLS (D). To block monoclonal 
ACPA binding, starved FLS were also stained with 1325:01B09 (red colour) pre-incubated with citrullinated (cit) or native fibrinogen (cit-Fib or Arg-
Fib, respectively) or in the absence of fibrinogen (E). Blocking experiments were performed with cit vimentin (cit-Vim), cit enolase (cit-Eno) and cit 
histone H4 (cit-His) with 10:1 decoy protein:antibody ratio (F). Migration indexes were obtained from three independent experiments, using cells of 
three individual patients and six replicates. In addition, monoclonal ACPA-induced migration was blocked by PAD inhibitor (200 nM Cl-amidine), but 
not by histone acetyltransferase or deacetylase inhibitors (10 µM anacardic acid, 0.2 µM trichostatin A) (G). FLS migration was also analysed in the 
presence of monoclonal ACPA or control IgG F(ab’)2 fragments at a concentration of 0.7 µg/mL. The graphs represent results from three independent 
experiments, using cells of three individual patients and six sample-replicates (H). Confocal images illustrate the binding of 1325:01B09, 1325:04C03 
and 1362:01E02 F(ab’)2 fragments (red colour) to starved FLS (nuclei shown in blue, origianl magnification 400X (I). Pre-incubation with citrullinated 
fibrinogen prevented 1325:01B09 F(ab’)2 fragments binding to starved FLS (nuclei shown in blue, original magnification 400X) (J). Nuclei are shown 
in blue. Original magnifications of 100x and 400x were used in light and confocal microscopy, respectively. Starved FLS were exposed to 1 µg/
mL 1325:01B09, 1362:01E02 or 0.7 µg/mL 1325:01B09 F(ab’)2. Immunoblot analysis of Akt phosphorylation (Thr308 residues) is shown, GAPDH 
protein was detected as control (K). ACPA, anticitrullinated protein/peptide antibody; DMSO,dimethyl sulfoxide; FLS, fibroblast-like synoviocytes; IHC, 
immunohistochemistry; PAD, protein arginine deiminase; ns, not significant.
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Figure 6 The monoclonal ACPA clones 1325:01B09 and 1325:04C03 bind to synovial targets in patients with RA but not in healthy controls. The 
immunohistochemistry images illustrate binding patterns of the monoclonal ACPA clones 1325:01B09 and 1325:04C03 to synovial tissues obtained 
from healthy donors (A) or patients with RA (B). Mouse IgG1 and the non-citrulline-specific 1362:01E02 (E02) monoclonal antibody were used as 
controls. CD55 and podoplanin (PDPN) stainings highlight FLS-rich areas of the synovial membrane. Immunohistochemistry stainings were analysed 
with light microscopy using 250x original magnification. (C) Confocal microscopy images illustrate a partial colocalisation of the ACPA clone 
1325:01B09 with CD55 (C) and PDPN (D), highlighted by closed arrows. Stainings with the monoclonal ACPA 1325:04C03 and the control 1362:01E02 
antibodies are also shown. Moreover, partially colocalisation of 1325:01B09 F(ab’)2 with PDPN were highlighted by arrows (E). An original 
magnification of 400x was used for confocal microscopy. ACPA, anticitrullinated protein/peptide antibody; DAPI, 4,6-diamidino-2-phenylindole; FLS, 
fibroblast-like synoviocytes; RA, rheumatoid arthritis.
often cause joint inflammation and have been associated with 
increased levels of pro-inflammatory cytokines and chemokines, 
including IL-8, as well as concomitant presence of the RF may 
contribute to synovial fibroblast sensitisation. A majority but 
not all individual polyclonal ACPA preparations show a similar 
migration promoting effect with the polyclonal ACPA pool, 
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suggesting that additional mechanisms than the ones presented 
in the current study might be active in a minority of ACPA-pos-
itive RA and certainly in a majority of ACPA-negative RA. This 
remain to be further investigated.
In contrast to OCs, no others tested RA-derived antibodies 
but ACPAs had an effect on FLS migration, suggesting a citrul-
lination dependency of the observed effect. As such, the paucity 
of citrullinated targets observed on steady-state FLS might 
explain the lack of ACPA effects in unchallenged conditions. 
Indeed, FLS that were challenged by either cellular stress or 
certain pro-inflammatory signals increased their expression of 
both PAD enzymes and citrullinated proteins, which sensitised 
the cells to ACPA effects. Cellular citrullination appears to be 
important for the ACPA-mediated FLS mobility, as PAD inhibi-
tion completely abolished this effect. While other cellular effects 
of these inhibitors cannot be completely excluded, the blocking 
experiments with soluble citrullinated proteins and the repro-
ducibility of the effects when using the F(ab’)2 ACPA fragments 
further strengthens this observation. Importantly, MDA modi-
fication, acetylation and homo-citrullination do not appear to 
influence FLS migration, as demonstrated by the lack of effect 
of anti-MDA antibodies, the lack of influence of increased or 
decreased acetylation on the ACPA effects and the migration 
promoting effects of both homo-citrullinated cross-reactive and 
non-cross-reactive monoclonal ACPAs.
While citrullination appears to be central for the ACPA effects 
on FLS, precise identification of the exact cellular target(s) is still 
a challenge. Although citrullinated fibrinogen has been previ-
ously proposed as an interstitial tissue target able to generate 
immune complexes in the presence of ACPA,41 our current 
findings suggest an additional mechanism where ACPAs might 
interact with surface cellular targets. As individual ACPAs are 
cross-reactive with a wide range of citrullinated peptides and 
proteins through their consensus motifs,4 as also confirmed by 
our blocking experiments, it remains to be determined which of 
these antigens are relevant for the observed effect. It has been 
suggested that ACPAs are prone to bind minute amounts of LPS 
that might interfere with interpretation of the functional effects 
observed with different ACPAs preparations.17 However, our 
LPS tests were negative and addition of different amounts of 
exogenous LPS to the FLS cultures with or without ACPAs had 
no effect on FLS migration (online supplementary figure 9).
FLS motility is governed by complex mechanisms, involving a 
large array of intracellular signalling pathways42–48 that mediate 
consecutive phases of this process: adhesion, migration and inva-
sion, with PI3K and MAPK playing central roles. We describe 
here a role for PI3K/Akt but not for MAPK phosphorylation in 
regulating ACPA-induced migration of challenged FLS. PI3K 
modulates organisation of actin cytoskeleton and lamellipodium 
formation via Akt phosphorylation, which can result in cytoskel-
eton remodelling and increased motility.49
A central finding of the current study resides in the selective 
cellular modulation by distinct monoclonal ACPAs. We show a 
selective increase of OC formation with the 1325:04C03 clone. 
This is in line with our previous reported increase of OC forma-
tion seen with the 1325:04C03 clone,4 that now reaches statistical 
significance at doses as low as 1 µg/mL, due to the larger number 
of replicates and the lower variability among the OC precursor 
cells donors. In spite of the typical cross-reactivity of ACPAs, 
this selective regulation suggests the targeting of non-overlap-
ping cellular autoantigens. The lack of Fcγ receptors on FLS, the 
identical IgG1 Fc regions in ACPA clones with different func-
tional effects and the positive effect of ACPA F(ab’)2 fragments 
on FLS migration suggest a role for specific-antigen binding 
in the observed ACPA effect. We propose that unique ACPA 
clones/specificities might be responsible for specific pathological 
features in distinct stages of the development of ACPA+RA and 
some of these effects might be dependent on additional stress/
inflammatory signals. Consequently, as ACPA fine-specificities 
are subjected to constant evolution and different ACPA combi-
nations are present in different individuals,50 the selective effects 
of individual ACPA clones could contribute to variability in the 
timing of arthritis development and in the symptoms present in 
seropositive individuals. Notably, this proposed role of ACPA 
is fully compatible with potential roles also of antibodies with 
other specificities in the generation of the various symptoms 
occurring before and during the course of RA.
In conclusion, we describe a novel potential pathogenic role 
for ACPAs in FLS migration. Our results also give further support 
for studies to investigate the early therapeutic and potentially 
preventive effect of drugs such as PAD enzymes inhibitors that 
affect the currently described mechanisms of FLS migration.
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